Algreen
Algreen (ALGRE.PA) Stock Overview
Explore Algreen’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.9M
P/E Ratio
-0.01
EPS (TTM)
$-1.20
ROE
-15.56%
ALGRE.PA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Algreen (ALGRE.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 4.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Algreen, together with its subsidiaries, operates in agri-food industry in Europe. It is also involved in the production of smoked salmon, caviar, and salmon roe; and marketing distribution of a functional sparkling drink based on CBD to supermarkets, cafes, hotels, restaurants, and in and out-of-home catering outlets. The company was formerly known as Les Toques Blanches du Monde Société Anonyme and changed its name to Algreen in July 2022. Algreen was incorporated in 2011 and is based in Lyon, France.
HA Tan Hieu
25
9 rue des Cuirassiers, Lyon
2014